Clinical Trials Logo
  1. Home
  2. Fertility Issues
  3. NCT05457413
  4. Details
NCT05457413 Clinical Trial

Impact of Bariatric Surgery on Women Fertility

Fertility Issues Clinical Trial

Official title:
Impact of Bariatric Surgery Induced Weight Loss on Women Fertility: A Prospective Cohort Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05457413
Other study ID # MS 392/2022
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 25, 2022
Est. completion date March 1, 2023

Study information
Verified date January 2023
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Obesity is a multifactorial risk factor for subfertility, in relation to chronic hormonal change induced by adipose tissue. This prospective cohort study aims to evaluate the impact of bariatric surgery induced weight loss on women fertility.

Description:

Females undergoing sleeve gastrectomy will be assessed for improvement of fertility indicators

Recruitment information / eligibility
Status Completed
Enrollment 75
Est. completion date March 1, 2023
Est. primary completion date December 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: - Age from 20-40 years. - BMI >35 kg/m2 Exclusion Criteria: - Women with medical endocrinal disorders as DM, thyroid, hyperprolactinaemia, etc. - Women using any hormonal treatment or fertility drugs like oral contraceptive pills and/or metformin. - Women have any surgical complication intra-operatively or post operatively. - Women refused to participate in the study.

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Sleeve gastrectomy
Bariatric surgery

Locations
Country Name City State
Egypt Ain Shams University Maternity Hospital Cairo Cairo/???????

Sponsors (1)
Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in Antimullerian hormone level Change in antimullerian hormone level 3 months
Secondary Change in serum FSH level 3 months
Secondary Change in serum LH level 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT06387498 - Testicular Tissue Cryopreservation (TTC) N/A
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Recruiting NCT05980091 - Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration. Phase 1
Recruiting NCT06043609 - Outcome Evaluation After Fertility Preservation
Not yet recruiting NCT05048771 - Fertility and Temporality in Pediatric Oncology
Completed NCT05368194 - Food Intake and Epigenetic Alteration in the Spermatozoa of Singletons and Twins N/A
Recruiting NCT05176535 - Determination of Vaginal Colonization and the Effect of an Oral Probiotic (PROSALVAG) N/A
Recruiting NCT06360471 - Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer
Recruiting NCT05271981 - Fertility After Uterine Artery Embolization
Recruiting NCT05815719 - Continuous Double Ovarian Stimulation. Phase 4
Recruiting NCT06127875 - Effects of Trying to Conceive Using an Home- or Hospital-based Ovulation Monitoring on Stress
Recruiting NCT05658848 - Effect of Collaborative Infertility Counseling on Coping Strategies and Marital Satisfaction N/A
Not yet recruiting NCT05385848 - Autologous Platelet-rich Plasma (PRP) Infusion to Improve Outcomes in Women With Ovarian Insufficiency: a Pilot Study N/A
Completed NCT04396210 - Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic
Completed NCT05134090 - Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation.
Completed NCT05905289 - Survival and Reproductive Outcomes of Malignant Ovarian Germ Cell Tumors
Recruiting NCT05316467 - Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma Phase 2/Phase 3
Completed NCT04600869 - Effects of Naturalistic Decision-Making Model-based Oncofertility Care Education N/A
Withdrawn NCT04683237 - Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia Phase 2/Phase 3
Not yet recruiting NCT06179420 - The Effectiveness of Advanced Decision Support Tool (OPT-IVF) for IVF Treatment